Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol

Journal of Clinical Endocrinology and Metabolism

Volumn 51, Issue 5, 1980, Pages 1107-1111

  Kuttenn, Frederique ^a,b   Rigaud, Catherine ^a,b   Wright, Franqoise ^a,b   Mauvais Jarvis, Pierre ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ESTRADIOL; ETHINYLESTRADIOL; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; TESTOSTERONE; TETRACOSACTIDE;

DRUG THERAPY; ENDOCRINE SYSTEM; HIRSUTISM; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; THERAPY;

ANDROSTENEDIONE; CYPROTERONE; CYPROTERONE ACETATE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMAN; HYDROXYPROGESTERONES; LUTEINIZING HORMONE; OVARY; TESTOSTERONE;

EID: 0019219827     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-51-5-1107     Document Type: Article

References (37)

1. Bardin CW, Lipsett MB 1967 Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 46:891
2. Kirshner MA, Bardin CW 1972 Androgen production and metabolism in normal and virilized women. Metabolism 21:667
3. Kuttenn F, Mowszowicz I, Schaison G, Mauvais-Jarvis P 1977 Androgen production and skin metabolism in hirsutism. J Endocrinol 75:83
4. Wiechert R 1967 Synthesen antiandrogener steroide. In: Advances in the Biosciences. Pergamon Press, New York, p 54
5. Hamada H, Neumann F, Junkmann K 1963 Intrauterine antimaskuline Beeinflussung von Rattenfeten durch ein stark gestogen wirkesames steroid. Acta Endocrinol (Copenh) 44:380
6. Neumann F, Berswordt-Wallrabe Von R, Eiger W, Steinbeck H, Hahn JD, Kramer M 1970 Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horm Res 26:337
7. Hammerstein J, Cupceancu B 1969 Behandlung des hirsutismus cyproterone acetat. Dtsch Med Wochenschr 94:829
8. Ismail AAA, Davidson DW, Sonka AR, Barnes EW, Irvine WJ, Kilimnik H, Van Der Beeken Y 1974 The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy. J Clin Endocrinol Metab 39:81
9. Beck P 1973 Contraceptive steroids: modifications of carbohydrate and lipid metabolism. Metabolism 22:841
10. Cain MD, Walters WA, Catt KJ 1971 Effects of oral contraceptive therapy on the renin-angiotensin system. J Clin Endocrinol Metab 33:671
11. Stern MP, Brown BW, Haskell NL, Farouhar JW, Wehrle CL, Wood PD 1976 Cardiovascular risk and use of estrogen or estrogenprogestogen combination. Stanford three community study. JAMA 235:811
12. Loeper J, Loeper J, Ohlghiesser C, de Lignieres B, Mauvais-Jarvis P 1977 Influence de l'estrogenotherapie sur les triglycerides. Nouv Presse Med 6:2747
13. Mauvais-Jarvis P 1979 En quoi les estrogenes naturels different des estrogenes synthetiques. Rev Prat 29:1687
14. Steg A, Benoit G, Limouzin-Lamotte A, Percutaneous 17β-estradiol in the treatment of prostatic cancer. 9th Meeting of the International Study Group for Steroid Hormones, Rome, December 1979, vol 11: xiv (Abstract)
15. Basdevant A, de Lignieres B Treatment of menopause by percutaneous administration of estradiol. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous Absorption of Steroids. Academic Press, New York, in press
16. Sitruk-Ware R, de Lignieres B, Basdevant A, Mauvais-Jarvis P 1980 Absorption of percutaneous estradiol in post-menopausal women. Maturitas, in press
17. Sitruk-Ware LR, Sterkers N, Mowszowicz I, Mauvais-Jarvis P 1977 Inadequate corpus luteal function in women with benign breast diseases. J Clin Endocrinol Metab 44:771
18. Wright F, Mowszowicz I, Mauvais-Jarvis P 1978 Urinary androstanediol radioimmunoassay: a new clinical evaluation. J Clin Endocrinol Metab 47:850
19. Bouchard P, Kuttenn F, Mowszowicz I, Schaison G, Raux-Eurin MC, Mauvais-Jarvis P, Congenital adrenal hyperplasia due to partial 21-hydroxylase deficiency. A study of five cases. Acta Endocrinol (Copenh), in press
20. Guillemant S, Thomopoulos P, Desgrez P 1969 Techniques de dosages par competition de quelques hormones steroides. In: Masson (ed) X° Reunion des Endocrinologistes de Langue Francaise. Paris, p 139
21. Pham-Huu-Trung MF, Gourmelen M, Raux-Eurin MC, Girard F 1978 Pituitary adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies. J Clin Endocrinol Metab 47:422
22. Schaison G, Mowszowicz I, Cesselin F, Lagoguey M 1977 Action antigonadotrope de la prolactine. Etude de 10 cas feminins d'hyperprolactinemie. Nouv Presse Med 6:425
23. Feldman RJ, Maibach HI 1969 Percutaneous penetration of steroid in man. J Invest Dermatol 52:89
24. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440
25. Cromencini C, Vignati E, Libroia A 1976 Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol. Acta Eur Fertil 7:299
26. Kuttenn F, Mowszowicz I, Mauvais-Jarvis P, Androgen metabolism in human skin. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous Absorption of Steroids. Academic Press, New York, in press
27. Mauvais-Jarvis P, Kuttenn F 1978 Hirsutisme idiopathique: role respectif de l'hypersecretion des androgenes et de leur metabolisme dans la peau. In: Scholler R (ed) Endocrinologie de l'Ovaire. SEPE, Paris, p 449
28. Mangan FR, Mainwaring WIP 1972 An explanation of the antiandrogenic properties of 6 a-bromo-17β-hydroxy-17α-methyl-4-oxa-5α-androstane-3-one. Steroids 20:331
29. Bolt HM, Kappus H, Kasbohrer R 1974 Metabolism of 17α-ethinylestradiol by human liver microsomes in vitro: aromatic hydroxylation and irreversible protein binding of metabolites. J Clin Endocrinol Metab 39: 1072
30. Eisenfeld AJ, Ajen RF, Weinberger MH 1978 Oral contraceptives possible mediation of side effects via an estrogen receptor in liver. Biochem Pharmacol 27:2571
31. Braendle W, Boess H, Breckwoldt M, Leven C, Bettendorf G 1974 Wirkung und Nebenwirkung des cyproteron acetat behandlung. Arch Gynaekol 216:335
32. Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F 1975 Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism, and virilism. J Steroid Biochem 6:827
33. Dewurst CJ, Underhill R, Goldmann S, Mansfield M 1977 The treatment of hirsutism with cyproterone acetate (an antiandrogen). Br J Obstet Gynaecol 84:119
34. Zieger G, Lux B, Kubatsch B 1972 The effect of cyproterone acetate on the adrenal of the male hamster. Acta Endocrinol (Copenh) 82: 127
35. Girard J, Baumann JB, Buchler U, Zuppinger K, Haas HG, Staub JJ, Wyss HI 1978 Cyproterone acetate and ACTH adrenal function. J Clin Endocrinol Metab 47:581
36. Panejar NS, Stitch SR 1976 Effects of cyproterone acetate on the biosynthesis of steroidal hormones. J Endocrinol 69:14
37. Jeffcoate WJ, Edwards CRW, Rees LH, Besser GM 1976 Cyproterone acetate. Lancet 2:1190